prednisone has been researched along with apremilast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armesto, S; Gómez-Fernández, C; González López, MA; González Vela, C; González-Gay, MA; Illaro, A; López Sundh, AE; Mayorga, J; Naharro Fernández, C; Palmou, N; Sánchez, J | 1 |
| Barete, S; Bouillet, L; Buffier, S; Cacoub, P; Comarmond, C; Fain, O; Gerfaud-Valentin, M; Gobert, D; Goulenok, T; Jamilloux, Y; Lazaro, E; Le Joncour, A; Misery, L; Saadoun, D; Sacre, K; Sève, P; Vautier, M; Vieira, M | 1 |
2 other study(ies) available for prednisone and apremilast
| Article | Year |
|---|---|
Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic.
Topics: Adult; Antibodies, Monoclonal, Humanized; COVID-19; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Methotrexate; Prednisone; Psoriasis; SARS-CoV-2; Thalidomide | 2020 |
Apremilast in Refractory Behçet's Syndrome: A Multicenter Observational Study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Behcet Syndrome; Cohort Studies; Colchicine; Drug Combinations; Female; France; Humans; Male; Middle Aged; Prednisone; Thalidomide; Treatment Outcome | 2020 |